# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000691
Filing Date
2024-05-09
Accepted
2024-05-09 16:01:50
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | atxs-20240331x10q.htm iXBRL | 10-Q | 1074043
2 | EX-31.1 | atxs-20240331xex31d1.htm | EX-31.1 | 12101
3 | EX-31.2 | atxs-20240331xex31d2.htm | EX-31.2 | 11281
4 | EX-32.1 | atxs-20240331xex32d1.htm | EX-32.1 | 7241
| Complete submission text file | 0001410578-24-000691.txt |  | 5054987

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | atxs-20240331.xsd | EX-101.SCH | 34475
6 | EX-101.CAL | atxs-20240331_cal.xml | EX-101.CAL | 38077
7 | EX-101.DEF | atxs-20240331_def.xml | EX-101.DEF | 153498
8 | EX-101.LAB | atxs-20240331_lab.xml | EX-101.LAB | 343467
9 | EX-101.PRE | atxs-20240331_pre.xml | EX-101.PRE | 236265
63 | EXTRACTED XBRL INSTANCE DOCUMENT | atxs-20240331x10q_htm.xml | XML | 846294

Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 24930307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)